Overview of Peptide Cancer Vaccine MarketThe Global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2024 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR ...

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

Read more about how occupational therapy interventions mitigate chemotherapy-induced cognitive impairment among women with breast cancer.

With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partners The project ...

Teachers, children and their families at Primrose School of East Cobb at Sprayberry came together to support one of their own, raising $750 and an outpouring of encouragement for a beloved teacher ...

The charity – founded in Birmingham more than 30 years ago – says it has enjoyed a significant period of impact, investment and collaboration in the fight ...

Background Behaviours across a 24-hour day, including physical activity, sedentary time and sleep, are disrupted following cancer and contribute to cancer-related outcomes. This study describes the ...

Last year, the Iowa Legislature took an important first step by passing legislation directing a comprehensive study into what ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...

"Since cancer happens where there are cells in your body, why have I never seen such thing as heart/muscles cancer?" ...

A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow Centre at the University of Würzburg.